Clopidogrel response variability has been identified in cats. In humans, evidence suggests that variable clopidogrel active metabolite (CAM) generation is the primary explanation for clopidogrel response variability with differences in body weight, sex, and variable metabolism of clopidogrel primarily due to polymorphisms of the gene encoding cytochrome P450 (CYP) 2C19 as some proposed mechanisms. The aim of this study was to evaluate whether variation in CAM concentrations exists in healthy cats and what the cause of such variation might be. Nineteen healthy cats were given 18.75 mg clopidogrel by mouth. Blood was collected 2 hr later. Plasma CAM concentrations were measured using high performance liquid chromatography and tandem mass spectrometry. Clopidogrel metabolism was estimated by calculating CAM metabolic ratio. DNA was collected, and feline CYP2C genotyping was performed. The cats demonstrated high interindividual variation of plasma CAM concentrations.Approximately 69% of this interindividual variation was primarily explained by differences in clopidogrel metabolism as measured by CAM metabolic ratio with some influence by sex but not by weight. A single nucleotide polymorphism was identified in the feline CYP2C gene that explained in part individual differences in CAM metabolic ratio and CAM plasma concentrations. K E Y W O R D S antiplatelet, antithrombotic, Plavix, thienopyridine, thromboprophylaxis | 17 LEE Et aL. response in cats is currently unknown. The aim of this study was to evaluate whether variations in CAM concentrations exist in healthy cats given the clinically used dose of 18.75 mg clopidogrel per os andwhat the cause of such variation might be. We hypothesized that interindividual variability in CAM plasma concentrations would be present and that this variability would be influenced by variability in cat weight, sex, metabolism, and/or CYP2C genetic polymorphisms.
| MATERIAL S AND ME THODS
| Animal inclusion criteriaEligible client-owned cats were required to be apparently healthy, between 2 and 8 years of age, and >3.4 kg in weight. Written informed owner consent was obtained prior to participation in the study. Apparent health was determined based on history, a normal physical examination, and normal laboratory values including complete blood count, serum biochemistry panel, urinalysis, negative feline leukemia virus and feline immunodeficiency virus testing, and a normal echocardiogram. All blood work and urinalyses were performed by the Washington State University Clinical Pathology Laboratory.All echocardiograms were performed by a single investigator (PML).Conventional 2D, M-mode, and Doppler examinations were performed using an echocardiographic system and transducers ranging from 4 to 10 MHz. This study was approved by the Washington State University Institutional Animal Care and Use Committee.